Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Vanda Strafella"'
Autor:
Nicola Sgherza, Daniela Di Gennaro, Paola Curci, Rita Rizzi, Daniela Roccotelli, Maria Croce, Martina Avantaggiato, Loredana Ruga, Vanda Strafella, Angelantonio Vitucci, Antonio Palma, Antonella V. Russo Rossi, Teresa Troiano, Angela M. V. Larocca, Maria Chironna, Silvio Tafuri, Francesco Albano, Pellegrino Musto
Publikováno v:
HemaSphere, Vol 6, Iss 12, p e800 (2022)
Externí odkaz:
https://doaj.org/article/2a6262732a324e758a9662a8e4cd2c92
Autor:
Nicola Sgherza, Paola Curci, Rita Rizzi, Vanda Strafella, Daniela Di Gennaro, Angelantonio Vitucci, Antonio Palma, Antonella Vita Russo Rossi, Francesco Albano, Pasquale Stefanizzi, Silvio Tafuri, Pellegrino Musto
Publikováno v:
Haematologica, Vol 107, Iss 2 (2021)
Externí odkaz:
https://doaj.org/article/dac746c95bdc477f89a31fd9936f763f
Autor:
Niccolo’ Bolli, Nicola Sgherza, Paola Curci, Rita Rizzi, Vanda Strafella, Mario Delia, Vito Pier Gagliardi, Antonino Neri, Luca Baldini, Francesco Albano, Pellegrino Musto
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 3, p 421 (2021)
Smoldering multiple myeloma (SMM), an asymptomatic plasma cell neoplasm, is currently diagnosed according to the updated IMWG criteria, which reflect an intermediate tumor mass between monoclonal gammopathy of undetermined significance (MGUS) and act
Externí odkaz:
https://doaj.org/article/2d877c1754104b1d8638650520cb6d3b
Autor:
Antonio Piccolomo, Claudia Pia Schifone, Vanda Strafella, Giorgina Specchia, Pellegrino Musto, Francesco Albano
Publikováno v:
Cancers, Vol 12, Iss 9, p 2528 (2020)
Immunomodulatory drugs (IMiDs) are analogs of thalidomide. They have immunomodulatory, antiangiogenic and proapoptotic properties and exert a role in regulating the tumor microenvironment. Recently IMiDs have been investigated for their pleiotropic p
Externí odkaz:
https://doaj.org/article/7d541e1d2b8547e2b7574f0e0236c20d
Autor:
Nicola Sgherza, Paola Curci, Rita Rizzi, Grazia Dell’Olio, Alberto Perfetto, Olga Battisti, Nicoletta Pizzileo, Vanda Strafella, Giovanni De Trizio, Teresa Troiano, Pasquale Stefanizzi, Silvio Tafuri, Pellegrino Musto
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:S122-S123
Autor:
Angelantonio Vitucci, Nicola Sgherza, Pellegrino Musto, Francesco Albano, Paola Curci, Antonio Palma, Vanda Strafella, Antonella Russo Rossi, Silvio Tafuri, Daniela Di Gennaro, Rita Rizzi, Pasquale Stefanizzi
Publikováno v:
Haematologica. 107(2)
Publikováno v:
Acta Bio Medica : Atenei Parmensis
Autor:
Paola Curci, Vanda Strafella, Daniela Di Gennaro, Luigi Vimercati, Antonella Russo Rossi, Pellegrino Musto, Rita Rizzi, Pasquale Stefanizzi, Silvio Tafuri, Antonio Palma, Francesco Albano, Nicola Sgherza, Angelantonio Vitucci
Publikováno v:
Blood
Introduction. Monoclonal Gammopathy of Undetermined Significance (MGUS) is a pre-malignant plasma cell disorder reported in approximately 3% of individuals aged > 50 years, characterized by a low risk (about 1% per year) of evolution into "overt" mye
Autor:
Vanda Strafella, Antonio Piccolomo, Pellegrino Musto, Claudia Pia Schifone, Giorgina Specchia, Francesco Albano
Publikováno v:
Cancers
Cancers, Vol 12, Iss 2528, p 2528 (2020)
Cancers, Vol 12, Iss 2528, p 2528 (2020)
Simple Summary Immunomodulatory drugs (IMiDs) are a class of molecules composed of thalidomide and its analogs. There is a growing interest in IMiDs on the treatment of acute myeloid leukemia (AML) patients. As AML has a worse prognosis, especially i
Autor:
Vito Pier Gagliardi, Mario Delia, Vanda Strafella, Antonino Neri, Niccolo Bolli, Rita Rizzi, Francesco Albano, Paola Curci, Nicola Sgherza, Luca Baldini, Pellegrino Musto
Publikováno v:
Journal of Clinical Medicine, Vol 10, Iss 421, p 421 (2021)
Journal of Clinical Medicine
Journal of Clinical Medicine
Smoldering multiple myeloma (SMM), an asymptomatic plasma cell neoplasm, is currently diagnosed according to the updated IMWG criteria, which reflect an intermediate tumor mass between monoclonal gammopathy of undetermined significance (MGUS) and act